One year after his last treatment, a 6-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastatic cancer.
http://www.pharmscope.com/Daily/DailyDetail.cfm?chosen=67028
http://www.pharmscope.com/Daily/DailyDetail.cfm?chosen=67028
No comments:
Post a Comment